Nascent Biotech Inc (NBIO)
0.0870
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Nascent Biotech Price to Book Value: 486.21 for June 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 486.21 |
| June 13, 2024 | 476.49 |
| June 12, 2024 | 476.49 |
| June 11, 2024 | 477.88 |
| June 10, 2024 | 540.26 |
| June 07, 2024 | 446.58 |
| June 06, 2024 | 541.60 |
| June 05, 2024 | 503.04 |
| June 04, 2024 | 503.04 |
| June 03, 2024 | 553.34 |
| May 31, 2024 | 553.34 |
| May 30, 2024 | 550.54 |
| May 29, 2024 | 556.69 |
| May 28, 2024 | 553.34 |
| May 24, 2024 | 545.29 |
| May 23, 2024 | 545.29 |
| May 22, 2024 | 556.69 |
| May 21, 2024 | 553.90 |
| May 20, 2024 | 553.34 |
| May 17, 2024 | 529.86 |
| May 16, 2024 | 503.04 |
| May 15, 2024 | 545.40 |
| May 14, 2024 | 556.13 |
| May 13, 2024 | 556.13 |
| May 10, 2024 | 557.81 |
| Date | Value |
|---|---|
| May 09, 2024 | 557.81 |
| May 08, 2024 | 553.34 |
| May 07, 2024 | 549.59 |
| May 06, 2024 | 557.81 |
| May 03, 2024 | 557.81 |
| May 02, 2024 | 557.81 |
| May 01, 2024 | 542.16 |
| April 30, 2024 | 558.37 |
| April 29, 2024 | 558.37 |
| April 26, 2024 | 558.37 |
| April 25, 2024 | 558.37 |
| April 24, 2024 | 558.37 |
| April 23, 2024 | 476.60 |
| April 22, 2024 | 502.20 |
| April 19, 2024 | 523.21 |
| April 18, 2024 | 516.17 |
| April 17, 2024 | 533.78 |
| April 16, 2024 | 533.78 |
| April 15, 2024 | 669.04 |
| April 12, 2024 | 613.98 |
| April 11, 2024 | 497.45 |
| April 10, 2024 | 496.33 |
| April 09, 2024 | 496.33 |
| April 08, 2024 | 473.69 |
| April 05, 2024 | 670.71 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
446.58
Minimum
Jun 07 2024
1031.22
Maximum
Mar 26 2024
643.44
Average
577.82
Median
Feb 28 2024
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 18.62 |
| iBio Inc | 0.8879 |
| Theriva Biologics Inc | 0.1415 |
| Oragenics Inc | 7.117 |
Price to Book Value Related Metrics
| Price | 0.0870 |
| Earnings Yield | -17.34% |
| Market Cap | 14.76M |
| Operating PE Ratio | 56.46 |
| Normalized PE Ratio | 10.12 |